AAPL 114.40 Apple Inc $AAPL Hit a 52 week high of 114.46

New Post Public Reply Private Reply Replies (0) Message Board

Nov 18, 2014 at 10:02 AM

AAPL 114.40 Apple Inc $AAPL Hit a 52 week high of 114.46 Closing the day 09:45 at 114.40 +0.41 +0.36% With a day low of 113.89 and a total volume of 2,828,547.

AAPL Recent Posts: http://investorshangout.com/Apple-Inc-AAPL-53191/

AAPL Apple Inc Recent Headline News

Let Them Eat iPads: Why Wage Suppression Is Key To The Market Puzzle
Mercenary Trader - Seeking Alpha - 19 mins ago
Many sacred cows have been slaughtered these past few years. Beliefs held as obvious, incontrovertible even, were crushed to dust. Take, for example, the notion that the United States was due to implode under the weight of accumulated debts. In a...
KBE: 33.44 (+0.06), SPY: 204.97 (+0.60), IWM: 116.82 (+1.10), AAPL: 114.39 (+0.40)

Apple Ties Up With UnionPay, Baidu Eyes 99Bill
Doug Young - Seeking Alpha - 20 mins ago
Bottom line: Apple’s new UnionPay tie-up is aimed at an eventual roll-out of its Apple Pay in China, while Baidu’s reported purchase of 99Pay marks a late but needed bid to boost its electronic payments capabilities. A couple of...
BIDU: 245.25 (+1.10), AAPL: 114.39 (+0.40), BABA: 113.10 (-1.15)

Critical Alerts For Apple, Ambarella, Cliffs Natural Resources, Keryx Biopharmaceuticals and Johnson Controls Released By InvestorsObserver
PR Newswire - 31 mins ago
InvestorsObserver issues critical PriceWatch Alerts for AAPL, AMBA, CLF, KERX and JCI.
AMBA: 51.15 (+2.37), CLF: 10.16 (-0.69), AAPL: 114.39 (+0.40), JCI: 49.89 (+0.17), KERX: 15.69 (+0.51)

Earnings Forecast Buzz for Baker Hughes, Halliburton, Apple, Gilead Sciences, Kinder Morgan, and Alibaba
PR Newswire - 1 hr 17 mins ago
EarningForecast.com has issued earnings forecast research with special focus on financial performance of the following stocks: Baker Hughes (NYSE:BHI), Halliburton (NYSE:HAL), Apple (NASDAQ:AAPL), Gilead Sciences (NASDAQ:GILD), Kinder Morgan (NYSE:KMI), and Alibaba (NYSE:BABA).
KMI: 40.84 (+0.59), GILD: 102.08 (+1.64), HAL: 49.93 (+0.70), AAPL: 114.39 (+0.40), BABA: 113.10 (-1.15), BHI: 66.03 (+0.80)

After InvenSense Stock Fell 35%, Is It a Buy?
Adam Levy, The Motley Fool - Motley Fool - 1 hr 31 mins ago
Shares of InvenSense are trading near a 52-week low three weeks after the company reported some very disappointing results in its fiscal second quarter. Despite picking up a big design win from Apple , the company missed expectations on the top...
INVN: 14.43 (+0.39), AAPL: 114.39 (+0.40)

Why Apple's Swift Programming Language Is a Diamond In the Rough
at The Street - 1 hr 47 mins ago
Apple’s WWDC development announcements, Swift, storyboards, and playgrounds a fresh look at WWDC innovations now after actually working with them.
AAPL: 114.38 (+0.39)

My First Dividend From Apple
Mark Farragher - at Seeking Alpha - Tue Nov 18, 3:44AM CST
Three months ago I decided I was going to be a dividend growth investor. Every month I would buy dividend growth stock and reinvest the dividend to take advantage of compound growth. In 15 years , my stock portfolio will grow large enough for me to...
AAPL: 114.38 (+0.39)

Apple, IBM, Cisco, Oracle Or Microsoft: Which Tech Giant Has The Most 'Effective' Buyback Program?
Brian Nichols - at Seeking Alpha - Mon Nov 17, 9:16PM CST

IBM: 163.59 (-0.57), MSFT: 49.09 (-0.37), AAPL: 114.38 (+0.39), ORCL: 41.33 (+0.17), CSCO: 26.53 (+0.06)

Should Dividend Investors Own Non-Dividend Paying Stocks?
Dividend Growth Investor - at Seeking Alpha - Mon Nov 17, 8:01PM CST
Dividend growth investing is the strategy I have been using for several years in order to reach my retirement goals. In order to be successful with a strategy and stick to it through thick and thin, investors need to understand its positives and...
KO: 42.87 (-0.05), MO: 49.21 (+0.16), PG: 87.51 (-0.33), AAPL: 114.38 (+0.39)

Watch Out Apple, Xiaomi Is Coming To Each One Of Your Segments
Lior Ronen - at Seeking Alpha - Mon Nov 17, 8:00PM CST

AAPL: 114.38 (+0.39)

Microsoft Corporation Continues to Distance Itself From Steve Ballmer
Tim Brugger, The Motley Fool - Motley Fool - Mon Nov 17, 7:17PM CST
Longtime Microsoft Chief Steve Ballmer, in August 2013, issued the now-infamous statement that he would retire "within the year." News of Ballmer's departure couldn't come soon enough for disgruntled shareholders, as evidenced by Microsoft's share...
GOOGL: 552.49 (+5.85), MSFT: 49.08 (-0.38), GOOG: 541.33 (+4.82), AAPL: 114.38 (+0.39), NOK: 7.92 (+0.25), CRM: 63.24 (+0.73)

Why the Apple Watch Won't Doom Fossil Group Inc
Bob Ciura, The Motley Fool - Motley Fool - Mon Nov 17, 7:15PM CST
While Apple shareholders and fans eagerly await the release of the Apple Watch, Fossil Group investors might be dreading that moment now slated for early 2015. That's because Fossil is highly dependent on sales of its watches. In the age of...
FOSL: 107.97 (+0.55), GOOGL: 552.49 (+5.85), INTC: 34.49 (+0.25), GOOG: 541.33 (+4.82), AAPL: 114.38 (+0.39)

Apple: Buybacks Plus Earnings Growth Yield At Least 20% Upside
Value Wagon - at Seeking Alpha - Mon Nov 17, 6:34PM CST

AAPL: 114.37 (+0.38)

Apple Pay's 3-Week Report Card Shows A Promising Start
ValueWalk - at Seeking Alpha - Mon Nov 17, 6:26PM CST
By Aman Jain Apple Pay is garnering decent number of users on a per store basis, but without NFC-enabled smartphones, the growth will be limited for now. Apple (NASDAQ: AAPL ) Pay service has witnessed a decent start, with Whole Foods (NASDAQ:...
AAPL: 114.39 (+0.40)

Apple Watch may outsell Fossil
at Investor's Business Daily - Mon Nov 17, 5:50PM CST
The tech giant's smartwatch could bring in 3 times as much revenue in its 1st year on the market as Fossil Group (FOSL) brought in over the last year, said RBC Capital Markets, which hiked its price target to 120 from 115 and reiterated an outperform...
FOSL: 107.97 (+0.55), AAPL: 114.39 (+0.40)

Most active Nasdaq-traded stocks
AP - Mon Nov 17, 5:02PM CST
NEW YORK (AP) — A look at Nasdaq 10 most-active stocks at the close of trading:
SPLS: 12.77 (-0.20), FB: 74.60 (+0.36), DNDN: 0.15 (unch), MSFT: 49.08 (-0.38), AAPL: 114.39 (+0.40), CSCO: 26.53 (+0.06)

Final Glance: Computer companies
AP - Mon Nov 17, 5:02PM CST
NEW YORK (AP) — Shares of some top computer companies were mixed at the close of trading:
IBM: 163.57 (-0.59), AAPL: 114.39 (+0.40), LXK: 43.36 (+0.34)

Apple Falls Despite UnionPay Deal, JD.com Plunges on Miss: Tech Winners & Losers
at The Street - Mon Nov 17, 4:40PM CST
ShoreTel takes a hit after suitor Mitel withdraws its buyout offer. Apple inched down, despite announcing an ecommerce partnership in China that could potentially yield billions of customers.
JD: 24.99 (-0.01), MITL: 10.20 (unch), AAPL: 114.39 (+0.40), SHOR: 7.54 (+0.13)

Intel Corporation Should Talk Connectivity on November 20
Ashraf Eassa, The Motley Fool - Motley Fool - Mon Nov 17, 4:30PM CST
Much of the focus around Intel 's mobile strategy has centered on the company's efforts to build competitive applications processors and cellular chipsets. In fact, at last year's investor meeting the company explicitly highlighted its...
BRCM: 42.32 (+0.14), QCOM: 70.51 (+0.11), INTC: 34.48 (+0.24), AAPL: 114.38 (+0.39)

Apple roundup: iPhone 6 supplies, UnionPay, Samsung/TSMC
Seeking Alpha - at Seeking Alpha - Mon Nov 17, 4:27PM CST

TSM: 21.98 (+0.07), AAPL: 114.38 (+0.39)

Apple Inc. (AAPL) Stock Research Links

AAPL Board Company Profile Buy Rating Time & Sales News Filings Financials

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Lilly's Sofe-M Shakes Up Ovarian Cancer Treatment

Ovarian Cancer Treatment Sees a New Challenger Alright, folks, Eli Lilly (NYSE:LLY) is stepping up with their latest findings in ovarian cancer treatment, and it's got plenty of people in a buzz. They've dropped new data for their investigational drug, Sofetabart mipitecan, or 'Sofe-M' for short, which targets this unrelenting disease with a punch that’s hard to ignore....

ASTS Faces Crucial Deadline Amidst Legal Turmoil

Ah, the ticking clock in the world of stock investments, where a nifty little thing called a class action lawsuit can flip your investment on its head. Right now, AST SpaceMobile (NASDAQ: ASTS) investors are staring down the barrel of one such lawsuit. With the November 13, 2026, deadline looming, it's time to sort the facts from the muck. Pins and Needles for ASTS...

World Young Scientist Summit 2026 in Wenzhou Kicks Off

Young Minds Meet AI Innovation Crack open the playbook, and it's clear: young brains from across the globe are gathering in Wenzhou, Zhejiang, China, to wrangle with AI and chart the course of science toward a sustainable future. The World Young Scientist Summit 2026 isn't just a parade of speeches and accolades. Nah, it's a deep dive into where innovative minds believe...

Survivors Secure $800M Settlement with NY Archdiocese

Massive Settlement: A Long-Awaited Justice Here's a different kind of news that's hitting like a thunderbolt. Over 1,300 survivors of abuse have finally struck a landmark deal with the Archdiocese of New York. Not only are the numbers staggering, but the relief for these individuals is palpable. We're talking about more than $800 million on the table here. That's some...

Bio-Thera's New Data: A Game Changer for NSCLC?

A Fresh Look at Lung Cancer Solutions There's fresh meat on the oncology block, with Bio-Thera Solutions swinging for the fences at ESMO 2026, spotlighting promising Phase 2 clinical data for their combo treatment in first-line non-small cell lung cancer (NSCLC). If you're tuned into the biopharmaceutical sector or just keeping tabs on global health romps, this news sets...

Swanson Nexus Pro Launch: Boost for Dietitians

By Lucas Young Updated Oct 24, 2026 Category News Views 160

Swanson Enters the Education Arena for Nutritionists Swanson Vitamins is mixing things up again! This time, they're launching something called Swanson Vitamins Nexus Pro, aimed squarely at the registered dietitians and licensed nutritionists crowd. Starting out as the place to grab your basic vitamins, Swanson's not resting on their supplement laurels. No, siree. They've...

CSTS Unveils PremierX in NYC: A Bold Entertainment Move

Welcome to the New Era of Entertainment Out of the blockbusters and into the open air, eh? On October 30, 2026, CSTS Enterprises flipped the New York skyline into a canvas for their grand kickoff of PremierXTM—a live entertainment brand poised to redefine how we gobble up our music, sport, and art. Now, there's a shot of adrenaline New Yorkers weren't exactly begging...

Alaska's Insurance Maze: Coverage Over Cheap Policies

Beyond Premiums: Assessing Real Coverage Needs The Alaskan wilderness isn't just home to stunning views; it's also a land where insurance needs to go beyond the average cookie-cutter policy. You'd think the cheapest option would suffice, but that's where residents might trip into financial quicksand. Devery Prince, a seasoned insurance principal, sheds light on why...

Axon Body 5: A Leap Forward in AI for Public Safety

Axon Raises the Stakes with Body 5 Camera Boy, oh boy, Axon's dropped a bombshell with the Body 5. We're talking a colossal leap into the AI era for public safety, and if you're in the biz, you can't just shrug this one off. We're looking at 25 times the AI processing power compared to Axon's old units. That's right, I said twenty-five. Real-time situational awareness in...

Apalutamide Boosts Outlook for Prostate Cancer Treatment

Fresh Findings on High-Risk Prostate Cancer Treatments In an industry that often feels like a game of chess, Johnson & Johnson's recent news unveils another one of their strategic moves with the announcement of breakthrough results from their Phase 3 PROTEUS substudy. Turns out, ERLEADA®, their apalutamide treatment, isn't just another pawn; it's a potential...